News

BioAdvance WorkShop

Immunome Presents Compelling Preclinical Data on Anti-IL-38 Antibody Program at the American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Annovis Bio Announces Positive Phase Two Efficacy Data for Treatment of Parkinson’s Disease
Renovacor Announces the Appointment of Kumar Dhanasekharan, Ph.D., as Senior Vice President of Technical Operations
Halo Labs Launches the Aura GT™ for Gene Therapy Product Quality
BioAdvance Announces ~$7M in Recent Investments and Leadership Transition